Aurora Cannabis (ACB) is pleased to announce the company’s discovery of a novel source of genetic resistance against powdery mildew, PM2, that ...

Aurora Cannabis has transformed its margins, market position, and balance sheet over the last few years, and the stock is now highly 'investible'. ACB's strategic focus on the global medical ...

The stock's fall snapped a two-day winning streak.

The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year ...

Aurora Cannabis (ACB) has announced today the company’s extended pastille offerings in Australia. This expansion marks another meaningful step in Aurora’s deep commitment to offering patients ...